SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nexalin Technology, Inc. (NXLIW) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 30/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NXLIW
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.75
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.50
Book Value / Share$0.00
Revenue / Share$0.02
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.69 |
$207.38K |
$-5.02M |
-2421.2% |
| 2020 |
$-0.48 |
$242.91K |
$-3.48M |
-1433.5% |
| 2021 |
$-0.85 |
$144.07K |
$-6.16M |
-4276.1% |
| 2022 |
$-0.26 |
$1.32M |
$-1.93M |
-145.7% |
| 2023 |
$-0.63 |
$110.75K |
$-4.65M |
-4197.6% |
| 2024 |
$-0.83 |
$168.72K |
$-7.61M |
-4508.7% |
| 2025 |
$-0.50 |
$301.65K |
$-8.22M |
-2725.8% |
